Trial
NCT01730157
Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Case Comprehensive Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Ciliary Body and Choroid Melanoma, Medium/Large Size
Intervention
ipilimumab
Why stopped
Research Cancelled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-10